多模态深度学习模型预测中重度及重度急性胰腺炎复发
回顾性收集235例中重度急性胰腺炎患者的临床数据与增强CT图像,按184例开发队列训练、51例独立验证队列评估,构建整合ResNet与ViT提取CT特征及临床危险因素的多模态深度学习模型APNet。APNet在独立测试集AUC为0.840,优于基于临床数据的LightGBM模型(AUC 0.711)和基于ResNet50的影像深度学习模型(AUC 0.815)。
要点
- APNet多模态模型预测中重度急性胰腺炎复发,独立测试集AUC为0.840。
- 影像深度学习ResNet50模型AUC为0.815,高于临床LightGBM模型的0.711。
- APNet在独立测试集准确率82.35%、精确率66.67%、召回率80.00%、F1分数72.73%。
核心结论
- APNet有效整合临床与影像数据,显著提高对中重度及重度急性胰腺炎复发的预测能力。
- 该多模态工具有助于早期识别高风险中重度及重度急性胰腺炎患者,支持针对性干预和改善长期结局。
研究设计与样本
- 回顾性收集235例中重度急性胰腺炎患者的临床数据与增强CT图像。
- 开发队列184例用于模型训练与内部交叉验证,独立验证队列51例用于性能评估。
- 先建立临床机器学习模型,再构建APNet多模态深度学习模型,通过多尺度融合将ResNet和ViT提取的CT特征与临床危险因素整合。
诊断标准与关键数值
- 基于临床数据的LightGBM模型AUC为0.711。
- 基于ResNet50的影像深度学习模型AUC为0.815。
- APNet多模态融合模型在独立测试集AUC为0.840,准确率82.35%、精确率66.67%、召回率80.00%、F1分数72.73%。
临床应用与阅片要点
- APNet在独立测试集上整体优于所有单模态模型,体现影像特征与临床危险因素结合的互补价值。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To overcome the limitations of single-modality predictors by developing and validating a multimodal model (APNet) that integrates clinical factors and contrast-enhanced CT features to predict recurrence of moderate-to-severe acute pancreatitis (MSAP/SAP).
METHODS: We retrospectively collected clinical data and enhanced CT images from a total of 235 patients with moderate-to-severe AP. To rigorously evaluate model generalizability, the dataset was divided into two distinct cohorts: a Development Cohort (N = 184) for model training and internal cross-validation, and an Independent Validation Cohort (N = 51) for performance evaluation. Clinical machine learning models were first developed, followed by APNet, a multimodal deep learning model integrating ResNet- and ViT-extracted CT features with clinical risk factors through multiscale fusion.
RESULTS: Among single-modality approaches, the LightGBM model using clinical data achieved an AUC of 0.711, while image-based deep learning with ResNet50 reached an AUC of 0.815. The proposed multimodal fusion model, APNet, showed the best predictive performance, achieving an AUC of 0.840 on the independent test set, with corresponding accuracy, precision, recall, and F1 score of 82.35%, 66.67%, 80.00%, and 72.73%. Overall, APNet consistently outperformed all single-modality models, highlighting the complementary value of combining imaging features with clinical risk factors.
CONCLUSION: APNet effectively integrates clinical and imaging data, significantly improving prediction of recurrence in MSAP/SAP patients. This multimodal tool can help identify high-risk MSAP and SAP patients early, supporting targeted interventions and better long-term outcomes.
引用
- Wan Z, Kong F, Min Y, et al. Multi-modal deep learning model for predicting recurrence of moderately severe and severe acute pancreatitis. Eur J Radiol. 2026. PMID: 41795349. doi:10.1016/j.ejrad.2026.112758
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。